Clinical Trial Update: Off-the-shelf NK Cells + SCT for Myeloid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating off-the-shelf natural killer (NK) cells in combination with stem cell transplantation for myeloid malignancies has completed enrollment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Off-the-shelf natural killer cell therapy (Allogeneic natural killer cells)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myeloid Malignancies, Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2025-12-19